nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—TNF—ankylosing spondylitis	0.604	1	CbGaD
Chloroquine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0371	0.121	CbGbCtD
Chloroquine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0318	0.104	CbGbCtD
Chloroquine—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0308	0.101	CbGbCtD
Chloroquine—ABCB1—Betamethasone—ankylosing spondylitis	0.0207	0.0675	CbGbCtD
Chloroquine—ABCB1—Prednisolone—ankylosing spondylitis	0.0204	0.0666	CbGbCtD
Chloroquine—ABCB1—Prednisone—ankylosing spondylitis	0.0193	0.0629	CbGbCtD
Chloroquine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0191	0.0622	CbGbCtD
Chloroquine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0185	0.0604	CbGbCtD
Chloroquine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0178	0.058	CbGbCtD
Chloroquine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0145	0.0472	CbGbCtD
Chloroquine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0124	0.0405	CbGbCtD
Chloroquine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0122	0.0399	CbGbCtD
Chloroquine—ABCB1—Dexamethasone—ankylosing spondylitis	0.012	0.0393	CbGbCtD
Chloroquine—CYP3A4—Prednisone—ankylosing spondylitis	0.0116	0.0377	CbGbCtD
Chloroquine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0113	0.037	CbGbCtD
Chloroquine—ABCB1—Methotrexate—ankylosing spondylitis	0.00968	0.0316	CbGbCtD
Chloroquine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00721	0.0235	CbGbCtD
Chloroquine—Personality change—Prednisolone—ankylosing spondylitis	0.0031	0.0488	CcSEcCtD
Chloroquine—Personality change—Triamcinolone—ankylosing spondylitis	0.00285	0.0449	CcSEcCtD
Chloroquine—Personality change—Methylprednisolone—ankylosing spondylitis	0.00284	0.0448	CcSEcCtD
Chloroquine—Personality change—Betamethasone—ankylosing spondylitis	0.00258	0.0408	CcSEcCtD
Chloroquine—Personality change—Dexamethasone—ankylosing spondylitis	0.00258	0.0408	CcSEcCtD
Chloroquine—TNF—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.00234	0.0888	CbGpPWpGaD
Chloroquine—Personality change—Prednisone—ankylosing spondylitis	0.00225	0.0355	CcSEcCtD
Chloroquine—Atrophy—Prednisolone—ankylosing spondylitis	0.00182	0.0287	CcSEcCtD
Chloroquine—Atrophy—Triamcinolone—ankylosing spondylitis	0.00167	0.0264	CcSEcCtD
Chloroquine—Atrophy—Methylprednisolone—ankylosing spondylitis	0.00167	0.0264	CcSEcCtD
Chloroquine—TNF—IL23-mediated signaling events—IL23R—ankylosing spondylitis	0.00155	0.0586	CbGpPWpGaD
Chloroquine—Atrophy—Betamethasone—ankylosing spondylitis	0.00152	0.024	CcSEcCtD
Chloroquine—Atrophy—Dexamethasone—ankylosing spondylitis	0.00152	0.024	CcSEcCtD
Chloroquine—Atrophy—Prednisone—ankylosing spondylitis	0.00132	0.0209	CcSEcCtD
Chloroquine—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00111	0.0419	CbGpPWpGaD
Chloroquine—Reaction gastrointestinal—Methotrexate—ankylosing spondylitis	0.00108	0.017	CcSEcCtD
Chloroquine—Myopathy—Prednisolone—ankylosing spondylitis	0.000846	0.0134	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—IL17A—ankylosing spondylitis	0.000816	0.0309	CbGpPWpGaD
Chloroquine—Myopathy—Triamcinolone—ankylosing spondylitis	0.000778	0.0123	CcSEcCtD
Chloroquine—Myopathy—Methylprednisolone—ankylosing spondylitis	0.000777	0.0123	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—IL12B—ankylosing spondylitis	0.000759	0.0287	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL12B—ankylosing spondylitis	0.000736	0.0279	CbGpPWpGaD
Chloroquine—Myopathy—Dexamethasone—ankylosing spondylitis	0.000706	0.0111	CcSEcCtD
Chloroquine—Myopathy—Betamethasone—ankylosing spondylitis	0.000706	0.0111	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000698	0.0264	CbGpPWpGaD
Chloroquine—TNF—TGF-beta Receptor Signaling—RUNX3—ankylosing spondylitis	0.000626	0.0237	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL17A—ankylosing spondylitis	0.000615	0.0233	CbGpPWpGaD
Chloroquine—Myopathy—Prednisone—ankylosing spondylitis	0.000615	0.0097	CcSEcCtD
Chloroquine—TNF—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000599	0.0227	CbGpPWpGaD
Chloroquine—Eruption—Methotrexate—ankylosing spondylitis	0.000586	0.00924	CcSEcCtD
Chloroquine—TNF—TNF receptor signaling pathway —TNFRSF1B—ankylosing spondylitis	0.00058	0.022	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL12B—ankylosing spondylitis	0.000572	0.0217	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000545	0.0206	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL1A—ankylosing spondylitis	0.000541	0.0205	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL10—ankylosing spondylitis	0.000538	0.0204	CbGpPWpGaD
Chloroquine—TNF—Matrix Metalloproteinases—MMP3—ankylosing spondylitis	0.000526	0.0199	CbGpPWpGaD
Chloroquine—Skin exfoliation—Triamcinolone—ankylosing spondylitis	0.000521	0.00822	CcSEcCtD
Chloroquine—Skin exfoliation—Methylprednisolone—ankylosing spondylitis	0.00052	0.0082	CcSEcCtD
Chloroquine—Delirium—Prednisone—ankylosing spondylitis	0.000501	0.00791	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000481	0.0182	CbGpPWpGaD
Chloroquine—Skin exfoliation—Betamethasone—ankylosing spondylitis	0.000473	0.00746	CcSEcCtD
Chloroquine—Skin exfoliation—Dexamethasone—ankylosing spondylitis	0.000473	0.00746	CcSEcCtD
Chloroquine—Visual disturbance—Prednisolone—ankylosing spondylitis	0.000455	0.00717	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.000445	0.00702	CcSEcCtD
Chloroquine—Skin exfoliation—Prednisone—ankylosing spondylitis	0.000412	0.0065	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000411	0.0156	CbGpPWpGaD
Chloroquine—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.000409	0.00646	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.000408	0.00644	CcSEcCtD
Chloroquine—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.000386	0.00609	CcSEcCtD
Chloroquine—TNF—FAS pathway and Stress induction of HSP regulation—IL1A—ankylosing spondylitis	0.00038	0.0144	CbGpPWpGaD
Chloroquine—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.000379	0.00598	CcSEcCtD
Chloroquine—Visual disturbance—Betamethasone—ankylosing spondylitis	0.000379	0.00598	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.000371	0.00586	CcSEcCtD
Chloroquine—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.000371	0.00586	CcSEcCtD
Chloroquine—TNF—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.000368	0.014	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000367	0.0139	CbGpPWpGaD
Chloroquine—TLR9—Immune System—KIR3DL1—ankylosing spondylitis	0.000362	0.0137	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000358	0.0136	CbGpPWpGaD
Chloroquine—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.000351	0.00554	CcSEcCtD
Chloroquine—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.000351	0.00554	CcSEcCtD
Chloroquine—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.000344	0.00543	CcSEcCtD
Chloroquine—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.000338	0.00534	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—IL17A—ankylosing spondylitis	0.000335	0.0127	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.000333	0.0126	CbGpPWpGaD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000329	0.0125	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—CARD9—ankylosing spondylitis	0.000327	0.0124	CbGpPWpGaD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000321	0.0122	CbGpPWpGaD
Chloroquine—TLR9—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000318	0.012	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—IL12B—ankylosing spondylitis	0.000312	0.0118	CbGpPWpGaD
Chloroquine—GSTA2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000308	0.0117	CbGpPWpGaD
Chloroquine—Psychotic disorder—Prednisone—ankylosing spondylitis	0.000306	0.00482	CcSEcCtD
Chloroquine—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000298	0.0047	CcSEcCtD
Chloroquine—Visual impairment—Prednisolone—ankylosing spondylitis	0.000287	0.00453	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000277	0.00437	CcSEcCtD
Chloroquine—Visual disturbance—Methotrexate—ankylosing spondylitis	0.000276	0.00436	CcSEcCtD
Chloroquine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000272	0.00429	CcSEcCtD
Chloroquine—TNF—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.000272	0.0103	CbGpPWpGaD
Chloroquine—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00027	0.00426	CcSEcCtD
Chloroquine—TNF—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000268	0.0101	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000264	0.01	CbGpPWpGaD
Chloroquine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000264	0.00416	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000254	0.00963	CbGpPWpGaD
Chloroquine—Neutropenia—Prednisone—ankylosing spondylitis	0.000253	0.00399	CcSEcCtD
Chloroquine—Hallucination—Betamethasone—ankylosing spondylitis	0.000247	0.0039	CcSEcCtD
Chloroquine—Hallucination—Dexamethasone—ankylosing spondylitis	0.000247	0.0039	CcSEcCtD
Chloroquine—Vision blurred—Prednisolone—ankylosing spondylitis	0.000245	0.00386	CcSEcCtD
Chloroquine—Visual impairment—Betamethasone—ankylosing spondylitis	0.00024	0.00378	CcSEcCtD
Chloroquine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00024	0.00378	CcSEcCtD
Chloroquine—Angioedema—Prednisolone—ankylosing spondylitis	0.000237	0.00374	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000236	0.00372	CcSEcCtD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000232	0.00879	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—IL1A—ankylosing spondylitis	0.000229	0.00869	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—IL10—ankylosing spondylitis	0.000228	0.00864	CbGpPWpGaD
Chloroquine—TNF—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000228	0.00864	CbGpPWpGaD
Chloroquine—Convulsion—Prednisolone—ankylosing spondylitis	0.000225	0.00355	CcSEcCtD
Chloroquine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000224	0.00353	CcSEcCtD
Chloroquine—TNF—Folate Metabolism—CRP—ankylosing spondylitis	0.000221	0.00839	CbGpPWpGaD
Chloroquine—Alopecia—Betamethasone—ankylosing spondylitis	0.00022	0.00347	CcSEcCtD
Chloroquine—Alopecia—Dexamethasone—ankylosing spondylitis	0.00022	0.00347	CcSEcCtD
Chloroquine—TLR9—Immune System—IL1R2—ankylosing spondylitis	0.00022	0.00832	CbGpPWpGaD
Chloroquine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000218	0.00344	CcSEcCtD
Chloroquine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000218	0.00343	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000217	0.00822	CbGpPWpGaD
Chloroquine—Hallucination—Prednisone—ankylosing spondylitis	0.000215	0.0034	CcSEcCtD
Chloroquine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000215	0.00339	CcSEcCtD
Chloroquine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000212	0.00334	CcSEcCtD
Chloroquine—Neutropenia—Methotrexate—ankylosing spondylitis	0.000211	0.00334	CcSEcCtD
Chloroquine—TLR9—Immune System—ERAP1—ankylosing spondylitis	0.000208	0.00789	CbGpPWpGaD
Chloroquine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000207	0.00326	CcSEcCtD
Chloroquine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000206	0.00326	CcSEcCtD
Chloroquine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000206	0.00325	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—HLA-C—ankylosing spondylitis	0.000205	0.00778	CbGpPWpGaD
Chloroquine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000202	0.00319	CcSEcCtD
Chloroquine—TNF—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000201	0.00761	CbGpPWpGaD
Chloroquine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.0002	0.00315	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000198	0.00752	CbGpPWpGaD
Chloroquine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000198	0.00312	CcSEcCtD
Chloroquine—Angioedema—Betamethasone—ankylosing spondylitis	0.000198	0.00312	CcSEcCtD
Chloroquine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000196	0.00309	CcSEcCtD
Chloroquine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000195	0.00307	CcSEcCtD
Chloroquine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000194	0.00307	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000194	0.00736	CbGpPWpGaD
Chloroquine—Insomnia—Prednisolone—ankylosing spondylitis	0.000192	0.00302	CcSEcCtD
Chloroquine—Alopecia—Prednisone—ankylosing spondylitis	0.000191	0.00302	CcSEcCtD
Chloroquine—TLR9—Immune System—CARD9—ankylosing spondylitis	0.00019	0.00721	CbGpPWpGaD
Chloroquine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000188	0.00297	CcSEcCtD
Chloroquine—Convulsion—Betamethasone—ankylosing spondylitis	0.000188	0.00296	CcSEcCtD
Chloroquine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000188	0.00296	CcSEcCtD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000185	0.007	CbGpPWpGaD
Chloroquine—Anxiety—Betamethasone—ankylosing spondylitis	0.000184	0.0029	CcSEcCtD
Chloroquine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000184	0.0029	CcSEcCtD
Chloroquine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000182	0.00286	CcSEcCtD
Chloroquine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000181	0.00286	CcSEcCtD
Chloroquine—Vision blurred—Prednisone—ankylosing spondylitis	0.000178	0.0028	CcSEcCtD
Chloroquine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000177	0.00279	CcSEcCtD
Chloroquine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000177	0.00279	CcSEcCtD
Chloroquine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000176	0.00278	CcSEcCtD
Chloroquine—TNF—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000176	0.00666	CbGpPWpGaD
Chloroquine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000176	0.00277	CcSEcCtD
Chloroquine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000174	0.00275	CcSEcCtD
Chloroquine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000174	0.00275	CcSEcCtD
Chloroquine—Agitation—Prednisone—ankylosing spondylitis	0.000173	0.00273	CcSEcCtD
Chloroquine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000173	0.00273	CcSEcCtD
Chloroquine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000173	0.00273	CcSEcCtD
Chloroquine—Angioedema—Prednisone—ankylosing spondylitis	0.000172	0.00272	CcSEcCtD
Chloroquine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000171	0.0027	CcSEcCtD
Chloroquine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000169	0.00266	CcSEcCtD
Chloroquine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000168	0.00266	CcSEcCtD
Chloroquine—Anorexia—Betamethasone—ankylosing spondylitis	0.000168	0.00266	CcSEcCtD
Chloroquine—Urticaria—Prednisolone—ankylosing spondylitis	0.000168	0.00265	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.000166	0.0063	CbGpPWpGaD
Chloroquine—Hypotension—Betamethasone—ankylosing spondylitis	0.000165	0.0026	CcSEcCtD
Chloroquine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000165	0.0026	CcSEcCtD
Chloroquine—Convulsion—Prednisone—ankylosing spondylitis	0.000163	0.00258	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000161	0.00609	CbGpPWpGaD
Chloroquine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00016	0.00253	CcSEcCtD
Chloroquine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00016	0.00253	CcSEcCtD
Chloroquine—Anxiety—Prednisone—ankylosing spondylitis	0.00016	0.00252	CcSEcCtD
Chloroquine—Alopecia—Methotrexate—ankylosing spondylitis	0.00016	0.00252	CcSEcCtD
Chloroquine—Insomnia—Betamethasone—ankylosing spondylitis	0.00016	0.00252	CcSEcCtD
Chloroquine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00016	0.00252	CcSEcCtD
Chloroquine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000155	0.00244	CcSEcCtD
Chloroquine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000154	0.00244	CcSEcCtD
Chloroquine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000154	0.00243	CcSEcCtD
Chloroquine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000154	0.00242	CcSEcCtD
Chloroquine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000154	0.00242	CcSEcCtD
Chloroquine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000154	0.00242	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000153	0.00241	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000153	0.00241	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.000152	0.00575	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.00015	0.00568	CbGpPWpGaD
Chloroquine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000148	0.00234	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000147	0.00557	CbGpPWpGaD
Chloroquine—Anorexia—Prednisone—ankylosing spondylitis	0.000147	0.00231	CcSEcCtD
Chloroquine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000146	0.0023	CcSEcCtD
Chloroquine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000146	0.0023	CcSEcCtD
Chloroquine—Urticaria—Betamethasone—ankylosing spondylitis	0.00014	0.00221	CcSEcCtD
Chloroquine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00014	0.00221	CcSEcCtD
Chloroquine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00014	0.0022	CcSEcCtD
Chloroquine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00014	0.0022	CcSEcCtD
Chloroquine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00014	0.0022	CcSEcCtD
Chloroquine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000139	0.0022	CcSEcCtD
Chloroquine—Insomnia—Prednisone—ankylosing spondylitis	0.000139	0.0022	CcSEcCtD
Chloroquine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000138	0.00217	CcSEcCtD
Chloroquine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000137	0.00217	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000137	0.00518	CbGpPWpGaD
Chloroquine—Convulsion—Methotrexate—ankylosing spondylitis	0.000137	0.00215	CcSEcCtD
Chloroquine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000134	0.00211	CcSEcCtD
Chloroquine—Rash—Prednisolone—ankylosing spondylitis	0.000134	0.00211	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—TLR4—ankylosing spondylitis	0.000133	0.00505	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000133	0.00504	CbGpPWpGaD
Chloroquine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000133	0.0021	CcSEcCtD
Chloroquine—Headache—Prednisolone—ankylosing spondylitis	0.000133	0.00209	CcSEcCtD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000132	0.00501	CbGpPWpGaD
Chloroquine—Confusional state—Methotrexate—ankylosing spondylitis	0.00013	0.00205	CcSEcCtD
Chloroquine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000129	0.00203	CcSEcCtD
Chloroquine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000127	0.002	CcSEcCtD
Chloroquine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000127	0.002	CcSEcCtD
Chloroquine—Asthenia—Betamethasone—ankylosing spondylitis	0.000127	0.002	CcSEcCtD
Chloroquine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000126	0.00199	CcSEcCtD
Chloroquine—Nausea—Prednisolone—ankylosing spondylitis	0.000126	0.00198	CcSEcCtD
Chloroquine—TNF—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000125	0.00475	CbGpPWpGaD
Chloroquine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000125	0.00197	CcSEcCtD
Chloroquine—Pruritus—Betamethasone—ankylosing spondylitis	0.000125	0.00197	CcSEcCtD
Chloroquine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000124	0.00195	CcSEcCtD
Chloroquine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000124	0.00195	CcSEcCtD
Chloroquine—Rash—Triamcinolone—ankylosing spondylitis	0.000123	0.00194	CcSEcCtD
Chloroquine—Anorexia—Methotrexate—ankylosing spondylitis	0.000123	0.00193	CcSEcCtD
Chloroquine—Rash—Methylprednisolone—ankylosing spondylitis	0.000123	0.00193	CcSEcCtD
Chloroquine—Urticaria—Prednisone—ankylosing spondylitis	0.000122	0.00193	CcSEcCtD
Chloroquine—Headache—Triamcinolone—ankylosing spondylitis	0.000122	0.00192	CcSEcCtD
Chloroquine—Headache—Methylprednisolone—ankylosing spondylitis	0.000122	0.00192	CcSEcCtD
Chloroquine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000122	0.00192	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—HLA-B—ankylosing spondylitis	0.000121	0.0046	CbGpPWpGaD
Chloroquine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000121	0.00191	CcSEcCtD
Chloroquine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000121	0.00191	CcSEcCtD
Chloroquine—Hypotension—Methotrexate—ankylosing spondylitis	0.00012	0.0019	CcSEcCtD
Chloroquine—TLR9—Immune System—HLA-C—ankylosing spondylitis	0.00012	0.00453	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000117	0.00443	CbGpPWpGaD
Chloroquine—Insomnia—Methotrexate—ankylosing spondylitis	0.000116	0.00183	CcSEcCtD
Chloroquine—Nausea—Triamcinolone—ankylosing spondylitis	0.000116	0.00182	CcSEcCtD
Chloroquine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000115	0.00182	CcSEcCtD
Chloroquine—Vomiting—Betamethasone—ankylosing spondylitis	0.000112	0.00177	CcSEcCtD
Chloroquine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000112	0.00177	CcSEcCtD
Chloroquine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000112	0.00176	CcSEcCtD
Chloroquine—Rash—Betamethasone—ankylosing spondylitis	0.000111	0.00176	CcSEcCtD
Chloroquine—Rash—Dexamethasone—ankylosing spondylitis	0.000111	0.00176	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000111	0.00175	CcSEcCtD
Chloroquine—Headache—Dexamethasone—ankylosing spondylitis	0.000111	0.00175	CcSEcCtD
Chloroquine—Headache—Betamethasone—ankylosing spondylitis	0.000111	0.00175	CcSEcCtD
Chloroquine—Asthenia—Prednisone—ankylosing spondylitis	0.00011	0.00174	CcSEcCtD
Chloroquine—Pruritus—Prednisone—ankylosing spondylitis	0.000109	0.00172	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—CRP—ankylosing spondylitis	0.000107	0.00406	CbGpPWpGaD
Chloroquine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000106	0.00167	CcSEcCtD
Chloroquine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000105	0.00166	CcSEcCtD
Chloroquine—Nausea—Betamethasone—ankylosing spondylitis	0.000105	0.00166	CcSEcCtD
Chloroquine—Nausea—Dexamethasone—ankylosing spondylitis	0.000105	0.00166	CcSEcCtD
Chloroquine—GSTA2—Metabolism—B3GNT2—ankylosing spondylitis	0.000105	0.00397	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL1RN—ankylosing spondylitis	0.000104	0.00393	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—TLR4—ankylosing spondylitis	0.000103	0.0039	CbGpPWpGaD
Chloroquine—Urticaria—Methotrexate—ankylosing spondylitis	0.000102	0.00161	CcSEcCtD
Chloroquine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000102	0.0016	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000101	0.00381	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.0001	0.00379	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.0001	0.00379	CbGpPWpGaD
Chloroquine—Vomiting—Prednisone—ankylosing spondylitis	9.78e-05	0.00154	CcSEcCtD
Chloroquine—Rash—Prednisone—ankylosing spondylitis	9.7e-05	0.00153	CcSEcCtD
Chloroquine—Headache—Prednisone—ankylosing spondylitis	9.64e-05	0.00152	CcSEcCtD
Chloroquine—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	9.55e-05	0.00362	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	9.51e-05	0.0036	CbGpPWpGaD
Chloroquine—Asthenia—Methotrexate—ankylosing spondylitis	9.23e-05	0.00146	CcSEcCtD
Chloroquine—Nausea—Prednisone—ankylosing spondylitis	9.14e-05	0.00144	CcSEcCtD
Chloroquine—TLR9—Immune System—CD79A—ankylosing spondylitis	9.12e-05	0.00345	CbGpPWpGaD
Chloroquine—Pruritus—Methotrexate—ankylosing spondylitis	9.1e-05	0.00144	CcSEcCtD
Chloroquine—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	8.81e-05	0.00334	CbGpPWpGaD
Chloroquine—Diarrhoea—Methotrexate—ankylosing spondylitis	8.8e-05	0.00139	CcSEcCtD
Chloroquine—Vomiting—Methotrexate—ankylosing spondylitis	8.18e-05	0.00129	CcSEcCtD
Chloroquine—Rash—Methotrexate—ankylosing spondylitis	8.11e-05	0.00128	CcSEcCtD
Chloroquine—Headache—Methotrexate—ankylosing spondylitis	8.06e-05	0.00127	CcSEcCtD
Chloroquine—Nausea—Methotrexate—ankylosing spondylitis	7.64e-05	0.00121	CcSEcCtD
Chloroquine—TLR9—Immune System—IL1A—ankylosing spondylitis	7.48e-05	0.00283	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CD40LG—ankylosing spondylitis	7.43e-05	0.00282	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	7.34e-05	0.00278	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	7.34e-05	0.00278	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PTGER4—ankylosing spondylitis	7.18e-05	0.00272	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-B—ankylosing spondylitis	7.07e-05	0.00268	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HLA-A—ankylosing spondylitis	6.55e-05	0.00248	CbGpPWpGaD
Chloroquine—TLR9—Immune System—CRP—ankylosing spondylitis	6.25e-05	0.00237	CbGpPWpGaD
Chloroquine—TLR9—Immune System—TLR4—ankylosing spondylitis	5.99e-05	0.00227	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MMP3—ankylosing spondylitis	5.11e-05	0.00194	CbGpPWpGaD
Chloroquine—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	3.8e-05	0.00144	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	2.65e-05	0.001	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—B3GNT2—ankylosing spondylitis	2.5e-05	0.000948	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	2.29e-05	0.000869	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	2e-05	0.000757	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	1.88e-05	0.000713	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.88e-05	0.000711	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	1.23e-05	0.000466	CbGpPWpGaD
